This is important if they are getting lightheaded or dizzy with lower readings, they may be hypotensive at home, but hypertensive at your office
Clinical trial data shows nausea affects approximately 44% of users, diarrhea hits about 30%, and vomiting is common especially during dose escalation
It states that at least 99% of peptide-related material in the sample is the target sequence, as measured by reverse-phase HPLC peak area
5) end-points, including efficacy outcomes [HbA1c, body weight, FPG, 2 h postprandial glucose (2 h PG), SBP, DBP, waist circumference, and lipid levels] and safety outcomes (hypoglycaemia, nausea, diarrhoea, vomiting, injection site-related events, urinary tract infection, genital infection etc.)
Food cravings diminish, portion sizes feel naturally smaller, and the urge to snack between meals often disappears
2018;16:E61E7